RENAL AND NEUROHUMORAL EFFECTS OF IBOPAMINE AND METOCLOPRAMIDE IN NORMAL MAN

被引:11
作者
GIRBES, ARJ
VANVELDHUISEN, DJ
SMIT, AJ
DRENTBREMER, A
MEIJER, S
REITSMA, WD
机构
[1] STATE UNIV GRONINGEN HOSP,DEPT INTERNAL MED,9713 EZ GRONINGEN,NETHERLANDS
[2] STATE UNIV GRONINGEN HOSP,THORAXCTR,9713 EZ GRONINGEN,NETHERLANDS
关键词
IBOPAMINE; METOCLOPRAMIDE; RENAL FUNCTION; DOPAMINERGIC AGENT;
D O I
10.1111/j.1365-2125.1991.tb05597.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of 100 mg ibopamine, an orally active nonselective dopamine agonist on renal haemodynamics, sodium excretion, blood pressure (BP), heart rate (HR) and neurohumoral parameters were investigated in 10 healthy volunteers, with and without metoclopramide pretreatment. A small and temporary rise of glomerular filtration rate (GFR) was found after ibopamine without but not with metoclopramide pretreatment. No differences in effective renal plasma flow (ERPF) but a small rise in sodium excretion were observed comparing ibopamine with control. Metoclopramide induced a fall in sodium excretion which was not reversed by ibopamine. Ibopamine failed to affect BP and HR and no changes of PRA or plasma aldosterone concentration (PAC) were found. Metoclopramide induced a pronounced increase of PAC which was blunted by ibopamine. Plasma and urinary catecholamines were unchanged for all study days. We conclude that ibopamine induces natriuresis probably not by the observed small and temporary renal haemodynamic effects but by direct stimulation of DA1 dopamine receptors in the proximal tubule.
引用
收藏
页码:701 / 704
页数:4
相关论文
共 18 条
[1]   TOTAL AND INTRARENAL FLOW DISTRIBUTION IN HEALTHY-SUBJECTS - TECHNIQUE, ACUTE EFFECTS OF IBOPAMINE AND OF INDORAMIN [J].
BRITTON, KE ;
NAWAZ, MK ;
NIMMON, CC ;
MLODKOWSKA, E ;
CARROLL, M ;
HORNE, T ;
GRANOWSKA, M .
NEPHRON, 1986, 43 (04) :265-273
[2]   CARDIOVASCULAR CHARACTERIZATION OF DA-1 AND DA-2 DOPAMINE RECEPTOR AGONISTS IN ANESTHETIZED RATS [J].
CAVERO, I ;
THIRY, C ;
PRATZ, J ;
LAWSON, K .
CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1987, 9 (5-6) :931-952
[3]  
DONKER AJM, 1977, NETH J MED, V20, P97
[4]  
FELDER RA, 1984, AM J PHYSIOL, V247, pF499, DOI 10.1152/ajprenal.1984.247.3.F499
[5]   ACUTE HEMODYNAMIC-EFFECTS OF IBOPAMINE IN PATIENTS WITH SEVERE CONGESTIVE HEART-FAILURE [J].
GHIRARDI, P ;
BRUSONI, B ;
MANGIAVACCHI, M ;
BIANCO, L ;
COL, J ;
METRA, M ;
CAS, LD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 19 (05) :613-618
[6]   DOPAMINERGIC BLOCKADE OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM - EFFECT OF HIGH AND LOW SODIUM INTAKES [J].
GORDON, MB ;
MOORE, TJ ;
DLUHY, RG ;
WILLIAMS, GH .
CLINICAL ENDOCRINOLOGY, 1983, 19 (04) :415-425
[7]   LACK OF EFFECT OF IBOPAMINE, A DOPAMINE PRO-DRUG, ON RENAL-FUNCTION IN NORMAL SUBJECTS [J].
HARVEY, JN ;
WORTH, DP ;
BROWN, J ;
LEE, MR .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (06) :671-677
[8]  
INCERTI PL, 1986, ARZNEIMITTEL-FORSCH, V36-1, P405
[9]   ENDOGENOUS DOPAMINE (DA) AND DA2 RECEPTORS - A MECHANISM LIMITING EXCESSIVE SYMPATHETIC-ADRENAL DISCHARGE IN HUMANS [J].
MANNELLI, M ;
PUPILLI, C ;
FABBRI, G ;
MUSANTE, R ;
DEFEO, ML ;
FRANCHI, F ;
GIUSTI, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 66 (03) :626-631
[10]   RENAL EFFECTS OF SB-7505 - A DOUBLE-BLIND-STUDY [J].
MELLONI, GF ;
MINOJA, GM ;
SCORAZZATI, G ;
BAUER, R ;
BRUSONI, B ;
GHIRARDI, P .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 19 (03) :177-180